Complementary Alternative Cardiovascular Medicine
Complementary Alternative Cardiovascular Medicine
Complementary Alternative Cardiovascular Medicine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
82 <strong>Alternative</strong> <strong>Cardiovascular</strong> <strong>Medicine</strong><br />
There was a 20% reduction in all-cause mortality (p = 0.01), and a 45%<br />
reduction in sudden death (p < 0.001) compared to the control group;<br />
vitamin E provided no additional benefit.<br />
Beneficial effects of ALA on CVD endpoints have also been shown<br />
in a widely cited randomized controlled clinical trial. The Lyon Heart<br />
Trial was a secondary prevention trial designed to test whether a Mediterranean-type<br />
diet, including increased amounts of ALA, would reduce<br />
reoccurrence rates of cardiac events, compared with a prudent Western<br />
diet (40). Subjects in the experimental group were instructed to adopt a<br />
Mediterranean-type diet that contained more bread, more root and green<br />
vegetables, more fish, fruit at least once daily, less red meat (replaced<br />
with poultry), and margarine high in ALA supplied by the study to replace<br />
butter and cream. This diet provided 30% of calories from fat, 8% from<br />
saturated fat, 13% from monounsaturated fat, 4.6% from polyunsaturated<br />
fat (0.84% ALA), and 203 mg/d of cholesterol. Despite a similar<br />
coronary risk factor profile (plasma lipids and lipoproteins, systolic and<br />
diastolic blood pressure, body mass index [BMI], and smoking status),<br />
subjects following the Mediterranean-type diet had a 50–70% lower risk<br />
of recurrent heart disease. There were marked reductions in cardiac<br />
death and nonfatal MI, major secondary endpoints, and minor events.<br />
Although the difference in ALA intakes between groups was 0.5 vs<br />
1.5 g/d, it is impossible to ascribe the benefit unambiguously to ALA,<br />
because there were many other dietary variables: saturated fat and<br />
cholesterol decreased and monounsaturated fat increased, as did the<br />
fruit and vegetable consumption. Nonetheless, this study has provided<br />
exciting, suggestive evidence that ALA has a cardioprotective effect.<br />
Further studies are needed to definitively establish the role of ALA.<br />
CONJUGATED LINOLEIC ACID<br />
Conjugated linoleic acid (CLA) comprises nine different positional<br />
and geometric isomers of linoleic acid in which the double bonds are<br />
conjugated instead of being in the typical methylene-interrupted configuration<br />
(41). Only two of the isomers, cis-9, trans-11 and trans-10,<br />
cis-12, are biologically active (1). They are formed from the microbial<br />
isomerization of dietary linoleic acid. CLA levels are higher in animal<br />
products than in plant products. Foods from ruminants, such as milk and<br />
meat, are the major dietary sources of CLA.<br />
CLA beneficially affects plasma lipids and lipoproteins, as well as<br />
atherosclerosis in rabbits (42) and hamsters (43). In both studies, the<br />
CLA treatment groups had markedly lower (approx 20%) total and LDL<br />
cholesterol levels and triglyceride levels. HDL cholesterol levels were